tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (JP:4519)
:4519
Japanese Market

Chugai Pharmaceutical Co (4519) Ratios

Compare
1 Followers

Chugai Pharmaceutical Co Ratios

JP:4519's free cash flow for Q1 2025 was ¥0.70. For the 2025 fiscal year, JP:4519's free cash flow was decreased by ¥ and operating cash flow was ¥0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.15 4.74 3.15 3.25 3.54
Quick Ratio
2.46 3.79 2.46 2.61 2.76
Cash Ratio
0.52 1.59 0.52 0.82 0.90
Solvency Ratio
0.91 1.16 0.91 0.95 0.96
Operating Cash Flow Ratio
0.58 1.42 0.58 0.85 0.87
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 891.17B¥ 1.06T¥ 891.17B¥ 712.98B¥ 579.41B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.31 1.19 1.31 1.30 1.26
Debt Service Coverage Ratio
6.65K 0.00 6.65K 6.96K 3.96K
Interest Coverage Ratio
8.74K 0.00 8.74K 8.79K 4.86K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
8.62 8.18 8.62 9.78 6.90
Net Debt to EBITDA
-0.37 -0.94 -0.37 -0.56 -0.61
Profitability Margins
Gross Profit Margin
62.20%62.81%62.20%66.18%65.25%
EBIT Margin
42.33%39.94%42.33%41.95%37.90%
EBITDA Margin
44.66%42.80%44.66%45.04%41.77%
Operating Profit Margin
42.33%39.52%42.33%42.20%38.28%
Pretax Profit Margin
42.16%39.93%42.16%41.95%37.89%
Net Profit Margin
29.72%29.29%29.72%30.31%27.29%
Continuous Operations Profit Margin
29.72%29.29%29.72%30.31%27.29%
Net Income Per EBT
70.49%73.33%70.49%72.25%72.01%
EBT Per EBIT
99.60%101.06%99.60%99.40%98.99%
Return on Assets (ROA)
20.03%16.84%20.03%19.69%17.38%
Return on Equity (ROE)
26.29%20.02%26.29%25.50%21.91%
Return on Capital Employed (ROCE)
36.88%26.71%36.88%34.83%30.14%
Return on Invested Capital (ROIC)
26.00%19.59%26.00%25.16%21.70%
Return on Tangible Assets
20.30%17.02%20.30%19.98%17.72%
Earnings Yield
6.76%3.70%6.76%4.93%2.37%
Efficiency Ratios
Receivables Turnover
2.46 3.49 2.46 2.81 3.11
Payables Turnover
2.27 7.62 2.27 2.22 2.72
Inventory Turnover
1.63 1.51 1.63 1.62 1.49
Fixed Asset Turnover
3.26 2.64 3.26 2.84 2.65
Asset Turnover
0.67 0.58 0.67 0.65 0.64
Working Capital Turnover Ratio
1.53 1.12 1.53 1.50 1.41
Cash Conversion Cycle
211.61 298.35 211.61 191.04 228.96
Days of Sales Outstanding
148.48 104.73 148.48 129.97 117.51
Days of Inventory Outstanding
223.95 241.52 223.95 225.42 245.45
Days of Payables Outstanding
160.82 47.90 160.82 164.36 134.00
Operating Cycle
372.43 346.25 372.43 355.40 362.96
Cash Flow Ratios
Operating Cash Flow Per Share
148.41 249.16 148.41 170.07 124.76
Free Cash Flow Per Share
105.10 204.03 105.10 125.75 87.39
CapEx Per Share
43.31 45.14 43.31 44.32 37.37
Free Cash Flow to Operating Cash Flow
0.71 0.82 0.71 0.74 0.70
Dividend Paid and CapEx Coverage Ratio
1.17 1.99 1.17 1.63 1.34
Capital Expenditure Coverage Ratio
3.43 5.52 3.43 3.84 3.34
Operating Cash Flow Coverage Ratio
17.30 30.47 17.30 17.43 18.17
Operating Cash Flow to Sales Ratio
0.19 0.37 0.19 0.28 0.26
Free Cash Flow Yield
3.12%3.82%3.12%3.37%1.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.80 27.00 14.80 20.27 42.12
Price-to-Sales (P/S) Ratio
4.40 7.91 4.40 6.14 11.49
Price-to-Book (P/B) Ratio
3.89 5.41 3.89 5.17 9.23
Price-to-Free Cash Flow (P/FCF) Ratio
32.04 26.18 32.04 29.70 62.97
Price-to-Operating Cash Flow Ratio
22.69 21.44 22.69 21.96 44.11
Price-to-Earnings Growth (PEG) Ratio
0.63 -2.06 0.63 0.49 1.16
Price-to-Fair Value
3.89 5.41 3.89 5.17 9.23
Enterprise Value Multiple
9.48 17.54 9.48 13.08 26.90
Enterprise Value
5.33T 8.34T 5.33T 5.89T 8.84T
EV to EBITDA
9.48 17.54 9.48 13.08 26.90
EV to Sales
4.23 7.51 4.23 5.89 11.24
EV to Free Cash Flow
30.84 24.86 30.84 28.48 61.57
EV to Operating Cash Flow
21.84 20.35 21.84 21.06 43.13
Tangible Book Value Per Share
850.71 976.00 850.71 709.21 581.78
Shareholders’ Equity Per Share
866.00 988.07 866.00 722.57 596.31
Tax and Other Ratios
Effective Tax Rate
0.30 0.27 0.30 0.28 0.28
Revenue Per Share
766.02 675.52 766.02 608.07 478.84
Net Income Per Share
227.64 197.83 227.64 184.29 130.66
Tax Burden
0.70 0.73 0.70 0.72 0.72
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.12 0.16 0.12 0.14 0.15
SG&A to Revenue
0.02 0.00 0.02 0.03 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.42 1.26 0.42 0.59 0.60
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis